Chapter 55 Biliary System
Anatomy And Physiology
The cystic duct drains the gallbladder, which is divided into the neck, infundibulum with Hartmann’s pouch, body, and fundus of the gallbladder. Roughly the size and shape of a common light bulb, the gallbladder holds 30 to 60 mL of bile as an extrahepatic reservoir. The gallbladder is attached to the inferior surface of the liver and is enveloped by liver for a variable portion of its circumference. Although some gallbladders are almost enveloped by liver parenchyma, others hang on a mesentery, predisposing to volvulus. The attachment of the gallbladder to the liver, known as the gallbladder fossa, identifies the separation of the left and right lobes of the liver (Fig. 55-2). Where the gallbladder attaches to the liver, Glisson’s capsule does not form, and this common surface provides the venous and lymphatic drainage of the gallbladder. The cystic duct drains at an acute angle into the common bile duct and can range from 1 to 5 cm in length. There are a number of anatomic variations in insertion of the cystic duct, including into the right hepatic duct (Fig. 55-3). Within the neck of the gallbladder and cystic ducts lie folds of mucosa oriented in a spiral pattern, known as the spiral valves of Heister, which act to keep gallstones from entering the common bile duct, in spite of distention and intraluminal pressure. The dependent portion of Hartmann’s pouch may overlie the common hepatic or right hepatic ducts, thus placing these structures at risk during the performance of a laparoscopic cholecystectomy.
Vascular Anatomy
The segmental anatomy of the liver parenchyma is based on the vascular supply and drainage, and the biliary drainage is described by the corresponding vascular segment. The hepatic parenchyma is divided into lobes, each of which is divided into lobar segments (Fig. 55-4) to define the basic hepatic anatomic resections. The left lobe is comprised of medial and lateral segments. The right lobe is divided into posterior and anterior segments. Alternatively, the hepatic parenchyma can be divided into segments based on the specific hepatic venous drainage and portal inflow, allowing for a more precise description of anatomic pathology. In this classification system, as developed by Couinard,1 the liver is composed of eight segments. Segment I refers to the caudate lobe. The left lobe of the liver, supplied by the left portal vein, constitutes segments II through IV. The left lobe is further subdivided by the falciform ligament, which separates segments II and III, also known as the left lateral segment, from segment IV. Within the left lateral segment, segment II lies superior to the insertion of the portal vein and segment III lies inferior to it. Segment IV is similarly divided into segments IVA, above, and segment IVB, below the portal vein insertion. The right portal vein supplies the right lobe of the liver and divides into the posterior and anterior sector. Each sector is then subdivided based on its relative location compared with the portal vein. Segment V is supplied by the inferior branch of the anterior sector and segment VIII is supplied by the superior branch. In the posterior sector, segment VI is supplied by the inferior branch and segment VII is supplied by the superior branch. There are three major hepatic veins that drain into the inferior vena cava, in addition to a number of small veins that drain directly from the right lobe. The right hepatic vein constitutes most of the venous drainage from the right lobe and generally lies in the intersegmental fissure between the anterior and posterior sectors of the right lobe. The middle hepatic vein drains the medial segment of the left lobe and a small amount of the medial portions of segments V and VIII. In most cases, the middle hepatic vein fuses with the left hepatic vein that drains the left lateral segment.
General Considerations In Biliary Tree Pathophysiology
Imaging Studies
Ultrasound
Transabdominal ultrasound is a sensitive, inexpensive, reliable, and reproducible test to evaluate most of the biliary tree, being able to separate patients with medical jaundice from those with surgical jaundice. Therefore, this modality is seen as the study of choice for the initial evaluation of jaundice or symptoms of biliary disease. The finding of a dilated common bile duct in the setting of jaundice suggests an obstruction of the duct from stones, usually associated with pain, or from a tumor, which is commonly painless (Fig. 55-9). Gallbladder diseases are regularly diagnosed by ultrasound, because its superficial location with no overlying bowel gas enables its evaluation by sound waves. Ultrasound has a high specificity and sensitivity for cholelithiasis, or gallstones. The density of gallstones allows crisp reverberation of the sound wave, showing an echogenic focus with a characteristic shadowing behind the stone (Fig. 55-10). Most gallstones, unless impacted, will move with positional changes in the patient. This feature allows their differentiation from gallbladder polyps, which are fixed, and from sludge which will move more slowly and does not have the sharp echogenic pattern of gallstones. Pathologic changes seen in many gallbladder diseases can be identified by ultrasound. For example, the gallbladder wall thickening and pericholecystic fluid seen in cholecystitis are visible by ultrasound (Fig. 55-11). Porcelain gallbladder, with its calcified wall, will appear as a curvilinear echogenic focus along the entire gallbladder wall, with posterior shadowing (Fig. 55-12). In addition to division of medical versus surgical jaundice, ultrasound can sometimes identify the cause of obstructive jaundice, showing common bile duct stones or even cholangiocarcinoma.
Hepatic Iminodiacetic Acid Scan
Although incapable of providing precise anatomic delineation of pathophysiology, biliary scintigraphy, also known as a hepatic iminodiacetic acid scan (HIDA) scan, can be used to evaluate the physiologic secretion of bile. The injection of an iminodiacetic acid, which is processed in the liver and secreted with bile, allows identification of bile flow. Therefore, the failure to fill the gallbladder 2 hours after injection demonstrates obstruction of the cystic duct, as seen in acute cholecystitis (Figs. 55-13 and 55-14). In addition, the scan will identify obstruction of the biliary tree and bile leaks, which may be useful in the postoperative setting. HIDA scans can also be used to determine gallbladder function, because the injection of CCK during a scan will document physiologic ejection of the gallbladder. This may be useful in patients with biliary tract pain but without stones, because some patients have pain from impaired emptying, known as biliary dyskinesia. As a nuclear medicine test, the test demonstrates physiologic flow, but does not provide fine anatomic detail, nor can it identify gallstones.
Endoscopic Ultrasound
Although of limited use in the evaluation of gallbladder pathology or intrahepatic disease of the biliary tree, endoscopic ultrasound (EUS) is valuable in the assessment of distal common bile duct and ampulla. With the close apposition of the distal common bile duct and pancreas to the duodenum, sound waves generated by EUS provide detailed evaluation of the bile duct and ampulla and have proven most useful in assessing tumors for invasion into vascular structures. Echoendoscopes are subdivided into those that scan perpendicular to the long axis of the endoscope, known as radial echoendoscopes, and those that scan parallel, known as linear echoendoscopes. Radial echoendoscopes are most useful for providing a tomographic evaluation (Fig. 55-18), whereas linear echoendoscopes can guide interventions such as needle biopsies under real-time ultrasound guidance (Fig. 55-19).
Benign Biliary Disease
Calculous Biliary Disease
Gallstones can be subclassified into two major subtypes, depending on the principle solute that precipitates into a stone. More than 70% of gallstones in America are formed by precipitation of cholesterol and calcium, with pure cholesterol stones accounting for only a small (<10%) portion. Pigment stones, further subclassified as black or brown stones, are caused by precipitation of concentrated bile pigments, the breakdown products of hemoglobin. Four major factors explain most gallstone formation—supersaturation of secreted bile, concentration of bile in the gallbladder, crystal nucleation, and gallbladder dysmotility. High concentrations of cholesterol and lipid in bile secretion from the liver constitute one predisposing condition to cholesterol stone formation, whereas increased hemoglobin processing is seen in most patients with pigment stones. Once in the gallbladder, bile is concentrated further through the absorption of water and NaCl, increasing the concentrations of the bile solutes and calcium. With respect to cholesterol stones (Fig. 55-20), cholesterol precipitates out into crystals when the concentration in vesicles exceeds the solubility of cholesterol (Fig. 55-21).2 This process of crystal formation is further accelerated by pronucleating agents, including glycoproteins and immunoglobulins. Finally, abnormal gallbladder motility can increase stasis in the gallbladder, allowing more time for solutes to precipitate in the gallbladder. Therefore, increased stone formation can be seen in conditions associated with impaired gallbladder emptying, such as prolonged fasting states, use of total parenteral nutrition, postvagotomy, and use of somatostatin analogues.
Acute Calculous Cholecystitis
Treatment
Cholecystectomy, whether open or laparoscopic, is the treatment of choice for acute cholecystitis. The timing of operative intervention in acute cholecystitis has long been a source of debate. In the past, many surgeons advocated for delayed cholecystectomy, with patients managed nonoperatively during their initial hospitalization and discharged home with resolution of symptoms. An interval cholecystectomy was then performed at approximately 6 weeks following the initial episode. More recent studies have shown that when performed early in the disease process (within the first week), the operation can be performed laparoscopically with equivalent or improved morbidity, mortality, and length of stay, as well as a similar conversion rate to open cholecystectomy.3 Additionally, approximately 20% of patients initially admitted for nonoperative management failed medical treatment prior to the planned interval cholecystectomy and required surgical intervention. Initial nonoperative therapy remains a viable option for patients who present in a delayed fashion and should be decided on an individual basis.
Choledocholithiasis
Many common duct stones are clinically silent and may be identified only during cholangiography, if performed routinely during cholecystectomy. Without pain or an abnormal liver function panel, a setting in which selective cholangiography is not performed, 1% to 2% of patients following cholecystectomy will present with a retained stone. When performed routinely, intraoperative cholangiography identifies choledocholithiasis in approximately 10% of asymptomatic patients, suggesting that most choledocholithiasis remains clinically silent.4,5
Treatment
Endoscopic Retrograde Cholangiopancreatography
Endoscopic sphincterotomy with stone extraction is effective for the treatment of choledocholithiasis. When used in the preoperative setting, it can avoid an open procedure and, when unsuccessful at removing stones, will alter intraoperative decision making. Common reasons for endoscopic failure include large stones, intrahepatic stones, multiple stones, altered gastric or duodenal anatomy, impacted stones, and duodenal diverticula. Sphincterotomy with stone extraction does not eliminate the risk of recurrent biliary stone disease. When managed by ERCP and sphincterotomy, almost 50% of all patients have recurrent symptoms of biliary tract disease if not also treated by cholecystectomy.6 More than one third of these patients eventually require cholecystectomy, suggesting that cholecystectomy should be offered to patients who present with choledocholithiasis. Interestingly, older patients (>70 years), have only a 15% rate of symptom recurrence, so cholecystectomy can be offered selectively to this patient population.
< div class='tao-gold-member'>
You may also need

Full access? Get Clinical Tree

